These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3978550)

  • 21. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer and oral contraceptive therapy in premenopausal women.
    Gambrell RD; Massey FM; Castaneda TA; Boddie AW
    J Reprod Med; 1979 Dec; 23(6):265-71. PubMed ID: 522080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No increase in breast cancer risk in Japanese women taking oral contraceptives: a case-control study investigating reproductive, menstrual and familial risk factors for breast cancer.
    Ichida M; Kataoka A; Tsushima R; Taguchi T
    Asian Pac J Cancer Prev; 2015; 16(9):3685-90. PubMed ID: 25987022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.
    Olsson H; Ranstam J; Baldetorp B; Ewers SB; Fernö M; Killander D; Sigurdsson H
    Cancer; 1991 Mar; 67(5):1285-90. PubMed ID: 1991290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.
    Rookus MA; van Leeuwen FE
    Lancet; 1994 Sep; 344(8926):844-51. PubMed ID: 7916400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
    Trivers KF; Gammon MD; Abrahamson PE; Lund MJ; Flagg EW; Moorman PG; Kaufman JS; Cai J; Porter PL; Brinton LA; Eley JW; Coates RJ
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1822-7. PubMed ID: 17855700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women.
    Plu-Bureau G; Thalabard JC; Sitruk-Ware R; Asselain B; Mauvais-Jarvis P
    Br J Cancer; 1992 Jun; 65(6):945-9. PubMed ID: 1616869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer in women who have taken contraceptive steroids.
    Matthews PN; Millis RR; Hayward JL
    Br Med J (Clin Res Ed); 1981 Mar; 282(6266):774-6. PubMed ID: 6783165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia.
    Ravnihar B; Primic Zakelj M; Kosmelj K; Stare J
    Neoplasma; 1988; 35(1):109-21. PubMed ID: 3352833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family history and oral contraceptives: unique relationships in breast cancer patients.
    Black MM; Kwon CS; Leis HP; Barclay TH
    Cancer; 1980 Dec; 46(12):2747-51. PubMed ID: 7448714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and benign breast disease: a case-control study.
    Franceschi S; La Vecchia C; Parazzini F; Fasoli M; Regallo M; Decarli A; Gallus G; Tognoni G
    Am J Obstet Gynecol; 1984 Jul; 149(6):602-6. PubMed ID: 6742041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contraceptive steroids and breast cancer.
    Spencer JD; Millis RR; Hayward JL
    Br Med J; 1978 Apr; 1(6119):1024-6. PubMed ID: 638582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study of oral contraceptive use and breast cancer.
    Hennekens CH; Speizer FE; Lipnick RJ; Rosner B; Bain C; Belanger C; Stampfer MJ; Willett W; Peto R
    J Natl Cancer Inst; 1984 Jan; 72(1):39-42. PubMed ID: 6363789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.